• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.17% Nasdaq Up0.24%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    3.59 Up 0.09(2.57%) 1:44PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 2,178   8,250   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit 2,178   8,250   -   -  
    Operating Expenses
    Research Development15,702  14,613  16,151  20,063  
    Selling General and Administrative4,717  16,005  4,889  5,393  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (18,241) (22,368) (21,040) (25,456)
    Income from Continuing Operations
    Total Other Income/Expenses Net48  96  98  65  
    Earnings Before Interest And Taxes(18,193)(22,272)(20,942)(25,391)
    Interest Expense -   -   -   -  
    Income Before Tax(18,193)(22,272)(20,942)(25,391)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(18,193)(22,272)(20,942)(25,391)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (18,193) (22,272) (20,942) (25,391)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (18,193) (22,272) (20,942) (25,391)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.